Probiome Therapeutics, Inc.

Biotechnology company · Ames, Iowa, United States

Probiome Therapeutics, Inc. is a biotechnology company headquartered in Ames, Iowa, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $254,063 in total, most recently in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Probiome Therapeutics at a glance

Typebiotechnology company

HeadquartersAmes, Iowa, United States

Employees (self-reported, 2021)2

What does Probiome Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $254,063 in total (2021). NIH funding came from the National Institute on Aging.

Frequently asked questions about Probiome Therapeutics

Where is Probiome Therapeutics headquartered?

Probiome Therapeutics, Inc. is headquartered in Ames, Iowa, United States.

What does Probiome Therapeutics do?

Probiome Therapeutics, Inc. is a biotechnology company.

Similar companies

MTI Biotech IncorporatedAmes, Iowa, United States
BioProtection Systems CorpAmes, Iowa, United States
Neovaxsyn IncAmes, Iowa, United States
PK Biosciences CorporationAmes, Iowa, United States
Mazen Animal Health Inc.Ames, Iowa, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences